journal article·2026-05-11Open access

Dietary Phytochemicals as Multi-Target Defenders Against Plastic-Associated Toxicity

Halina Tkaczenko, Renata Kołodziejska, Oleksandr Lukash, Oleksandr Yakovenko, Lyudmyla Buyun, Ivan Kirvel, Piotr Kamiński, Natalia Kurhaluk

Applied Sciences· Volume 16· Issue 10

Abstract

Plastic-derived chemical additives, including bisphenols, phthalates, perfluoroalkyl substances (PFAS) and microplastic-associated contaminants, are now recognised as widespread environmental toxins that measurably affect endocrine signalling, oxidative balance, inflammation and metabolic homeostasis. Continuous exposure through food contact materials, consumer products, and environmental media raises concerns about long-term health effects. An increasing number of epidemiological and experimental studies are linking these exposures to metabolic disorders, reproductive dysfunction, neurodevelopmental alterations, and increased disease susceptibility throughout the lifespan. This narrative review summarises the latest evidence on the toxicological mechanisms of these compounds, with a focus on endocrine disruption, redox imbalance, reproductive impairment, thyroid hormone dysregulation and epigenetic modifications induced by plastic-derived chemicals. Literature was identified through searches of major scientific databases, including PubMed, Scopus, and Web of Science. Reference screening was also employed to complement these searches and ensure comprehensive coverage of vertebrate and invertebrate models. The inclusion criteria encompassed studies published within the last 10 years, focusing on experimental, experimental, and translational research. The review evaluates phytochemicals such as polyphenols, flavonoids, isoflavones, catechins, sulforaphane, and chlorogenic acid as natural agents that can mitigate the biological effects of plastic-derived toxicants. These compounds exhibit antioxidant, anti-inflammatory, and receptor-modulating properties that counteract pathways disrupted by BPA, phthalates, and PFAS. Experimental studies have demonstrated that phytochemicals can modulate oestrogen receptor activity, enhance detoxification systems, reduce oxidative biomarkers and mitigate epigenetic and metabolic alterations induced by micro- and nanoplastics. Emerging nutritional evidence suggests that diets high in polyphenols may reduce the biological impact of plastic-derived contaminants within the body, rather than reducing exposure itself. This effect appears to be especially relevant during sensitive developmental periods, such as the prenatal, early postnatal and adolescent stages.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Effects and risks of endocrine disrupting chemicals · Microplastics and Plastic Pollution · Per- and polyfluoroalkyl substances research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Institute of Biology, Pomeranian University in Słupsk, 76-200 Slupsk, Poland

Division of Ecology and Environmental Protection, Department of Medical Biology and Biochemistry, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, 85-094 Bydgoszcz, Poland

Department of Ecology, Geography and Nature Management, T.H. Shevchenko National University “Chernihiv Colehium”, 14000 Chernihiv, Ukraine

Department of Tropical and Subtropical Plants, M.M. Gryshko National Botanic Garden, National Academy of Sciences of Ukraine, 01103 Kyiv, Ukraine

Institute of Geography, Pomeranian University in Słupsk, 76-200 Slupsk, Poland

Department of Nature Conservation, Institute of Biological Sciences, Faculty of Biological Sciences, University of Zielona Góra, 65-516 Zielona Gora, Poland

References (100+)

Show source-provided references
1. A combinational threat of micro- and nano-plastics (MNPs) as potential emerging vectors for per- and polyfluoroalkyl substances (PFAS) to human health10.1007/s10661-024-13292-9 ↗
2. Trophic transfer and interfacial impacts of micro(nano)plastics and per- and polyfluoroalkyl substances in the environment10.1016/j.jhazmat.2023.133243 ↗
3. Microplastics in ecosystems: Critical review of occurrence, distribution, toxicity, fate, transport, and advances in experimental and computational studies in surface and subsurface water10.1016/j.jenvman.2024.122492 ↗
4. Human consumption of microplastics10.1021/acs.est.9b01517 ↗
5. Developmental origins of non-communicable disease: Implications for research and public health10.1186/1476-069X-11-42 ↗
6. Sobral, A.F., Cunha, A., Costa, I., Silva-Carvalho, M., Silva, R., and Barbosa, D.J. (2025). Environmental xenobiotics and epigenetic modifications: Implications for human health and disease. J. Xenobiot., 15.10.3390/jox15040118 ↗
7. Microplastics in freshwater and marine ecosystems: Occurrence, characterization, sources, distribution dynamics, fate, transport processes, potential mitigation strategies, and policy interventions10.1016/j.ecoenv.2025.118036 ↗
8. Kovacs, K., Bodis, J., and Vass, R.A. (2025). Microplastics, endocrine disruptors, and oxidative stress: Mechanisms and health implications. Int. J. Mol. Sci., 27.10.3390/ijms27010399 ↗
9. Toxicological interactions of microplastics/nanoplastics and environmental contaminants: Current knowledge and future perspectives10.1016/j.jhazmat.2020.123913 ↗
10. Recent advances in toxicological research and potential health impact of microplastics and nanoplastics in vivo10.1007/s11356-022-19745-3 ↗
11. Ullah, S., Ahmad, S., Guo, X., Ullah, S., Ullah, S., Nabi, G., and Wanghe, K. (2023). A review of the endocrine disrupting effects of micro and nano plastic and their associated chemicals in mammals. Front. Endocrinol., 13.10.3389/fendo.2022.1084236 ↗
12. Bora, S.S., Gogoi, R., Sharma, M.R., Borah, M.P., Deka, P., Bora, J., Naorem, R.S., Das, J., and Teli, A.B. (2024). Microplastics and human health: Unveiling the gut microbiome disruption and chronic disease risks. Front. Cell. Infect. Microbiol., 14.10.3389/fcimb.2024.1492759 ↗
13. Chulkov, V., Gasanov, M., Isakov, V., Denisenko, A., Nwosu, C., and Rodkin, S. (2025). Molecular and cellular effects of microplastics and nanoplastics in the pathogenesis of cardiovascular, nervous, urinary, digestive, and reproductive system diseases: A global systematic review. Int. J. Mol. Sci., 26.10.3390/ijms262211194 ↗
14. Bhattacharyya, S., Greer, M.L., and Salehi, M. (2025). Impact of micro- and nanoplastics exposure on human health: Focus on neurological effects from ingestion. Front. Public Health, 13.10.3389/fpubh.2025.1681776 ↗
15. Environmental samples of microplastics induce significant toxic effects in fish larvae10.1016/j.envint.2019.105047 ↗
16. Principi, N., Argentiero, A., Campana, B.R., Seferi, H., Cinti, E., and Esposito, S. (2025). Plastic pollution and child health: A narrative review of micro- and nanoplastics, additives, and developmental risks. J. Clin. Med., 14.10.3390/jcm14238399 ↗
17. Fanghella, F., Pesce, M., Franceschelli, S., Panella, V., Elsallabi, O., Lupi, T., Rizza, B., Di Battista, M.G., Bruno, A., and Ballerini, P. (2025). Biological modulation of autophagy by nanoplastics: A current overview. Int. J. Mol. Sci., 26.10.3390/ijms26157035 ↗
18. Innovations in the development of promising adsorbents for the remediation of microplastics and nanoplastics—A critical review10.1016/j.watres.2022.119526 ↗
19. Application of carbon-based adsorbents in the remediation of micro- and nanoplastics10.1016/j.jenvman.2023.119522 ↗
20. Tripathi, M., Singh, P., Pathak, S., Manimekalai, R., Garg, D., and Dashora, K. (2025). Strategies for the remediation of micro- and nanoplastics from contaminated food and water: Advancements and challenges. J. Xenobiot., 15.10.3390/jox15010030 ↗
21. Liang, N., and Kitts, D.D. (2016). Role of chlorogenic acids in controlling oxidative and inflammatory stress conditions. Nutrients, 8.10.3390/nu8010016 ↗
22. Oxidative stress and inflammation: What polyphenols can do for us?10.1155/2016/7432797 ↗
23. The beneficial effects of quercetin, curcumin, and resveratrol in obesity10.1155/2017/1459497 ↗
24. The role of gut microbiota in MP/NP-induced toxicity10.1016/j.envpol.2024.124742 ↗
25. Current status of using adsorbent nanomaterials for removing microplastics from water supply systems: A mini review10.3762/bjnano.16.127 ↗
26. Di Giacomo, A., Russo, G.L., Moccia, S., Spagnuolo, C., and Russo, M. (2026). Phytochemicals possess selective chemopreventive mechanisms that safeguard human cells from oxidative toxicity. Biomolecules, 16.10.3390/biom16020191 ↗
27. Protective effects of polyphenols against endocrine disrupting chemicals10.1007/s10068-022-01105-z ↗
28. Polyphenols regulate the activity of endocrine-disrupting chemicals, having both positive and negative effects10.3390/jox14040077 ↗
29. Bas, T.G. (2026). Dietary polyphenols (flavonoids) derived from plants for use in therapeutic health: Antioxidant performance, ROS, molecular mechanisms, and bioavailability limitations. Int. J. Mol. Sci., 27.10.3390/ijms27031404 ↗
30. Transactivation of genes encoding for phase II enzymes and phase III transporters by phytochemical antioxidants10.3390/molecules15096332 ↗
31. Stoian, I.A., Vlad, A., Gilca, M., and Dragos, D. (2025). Modulation of glutathione-S-transferase by phytochemicals: To activate or inhibit—That is the question. Int. J. Mol. Sci., 26.10.3390/ijms26157202 ↗
32. Mehta, J., Rayalam, S., and Wang, X. (2018). Cytoprotective effects of natural compounds against oxidative stress. Antioxidants, 7.10.3390/antiox7100147 ↗
33. Mączka, W., Grabarczyk, M., and Wińska, K. (2022). Can antioxidants reduce the toxicity of bisphenol?. Antioxidants, 11.10.3390/antiox11020413 ↗
34. Endocrine-disrupting chemicals: Do polyphenols advantage or counteract their activity?10.31083/j.fbl2910344 ↗
35. Wang, Z., Wang, Y., Zhang, J., Feng, G., Miao, S., Lu, R., Tian, X., and Ye, Y. (2025). Antioxidant intervention against microplastic hazards. Antioxidants, 14.10.3390/antiox14070797 ↗
36. Dietary phytochemicals in health and disease: Mechanisms, clinical evidence, and applications—A comprehensive review10.1002/fsn3.70101 ↗
37. Singh, D.D., Yadav, D.K., and Shin, D. (2026). Phytochemicals and redox modulation: Molecular mechanisms, clinical relevance, and therapeutic perspectives. Antioxidants, 15.10.3390/antiox15020272 ↗
38. Cimmino, I., Fiory, F., Perruolo, G., Miele, C., Beguinot, F., Formisano, P., and Oriente, F. (2020). Potential mechanisms of bisphenol A (BPA) contributing to human disease. Int. J. Mol. Sci., 21.10.3390/ijms21165761 ↗
39. Della Rocca, Y., Traini, E.M., Diomede, F., Fonticoli, L., Trubiani, O., Paganelli, A., Pizzicannella, J., and Marconi, G.D. (2023). Current evidence on bisphenol A exposure and the molecular mechanism involved in related pathological conditions. Pharmaceutics, 15.10.3390/pharmaceutics15030908 ↗
40. Bisphenol A distribution in serum, urine, placenta, breast milk, and umbilical cord serum in a birth panel of mother–neonate pairs10.1016/j.scitotenv.2017.10.042 ↗
41. Concentrations of bisphenol A in adults from the general population: A systematic review and meta-analysis10.1016/j.scitotenv.2021.145755 ↗
42. Non-monotonic dose responses in studies of endocrine disrupting chemicals: Bisphenol A as a case study
43. Epigenetic perspective on the developmental effects of bisphenol A10.1016/j.bbi.2011.02.005 ↗
44. Lee, J.L., Wang, Y.C., Hsu, Y.A., Chen, C.S., Weng, R.C., Lu, Y.P., Chuang, C.Y., and Wan, L. (2022). Bisphenol A coupled with a high-fat diet promotes hepatosteatosis through reactive oxygen species-induced CD36 overexpression. Toxics, 10.10.3390/toxics10050208 ↗
45. Disruption of PPARG activity and CPT1A regulation by bisphenol A: Implications for hepatic lipid metabolism10.1111/jcmm.70416 ↗
46. Impact of polystyrene microplastic exposure on lipid profile and oxidative stress status of male and female Wistar rats10.5620/eaht.2022024 ↗
47. Salau, E.A.H., Diglio, D., Guimarães, G.R., Furtado-Filho, O.V., and Porawski, M. (2025). Bisphenol A alters the expression of genes involved in lipogenesis, inflammation, and oxidative stress in the liver of adult zebrafish. Pharmaceuticals, 18.10.3390/ph18111765 ↗
48. Liu, R., Liu, B., Tian, L., Jiang, X., Li, X., Cai, D., Sun, J., Bai, W., and Jin, Y. (2022). Exposure to bisphenol A caused hepatotoxicity and intestinal flora disorder in rats. Int. J. Mol. Sci., 23.10.3390/ijms23148042 ↗
49. G protein-coupled estrogen receptor activation by bisphenol A disrupts lipid metabolism and induces ferroptosis in the liver10.1016/j.envpol.2023.122211 ↗
50. Involvement of the G-protein-coupled estrogen receptor-1 (GPER) signaling pathway in neurodegenerative disorders: A review10.1007/s10571-022-01301-9 ↗
51. Xu, F., Ma, J., Wang, X., Wang, X., Fang, W., Sun, J., Li, Z., and Liu, J. (2023). The role of G protein-coupled estrogen receptor (GPER) in vascular pathology and physiology. Biomolecules, 13.10.3390/biom13091410 ↗
52. Bisphenols and their role in female infertility and hormone-related cancer10.1007/s12020-025-04521-3 ↗
53. Bisphenol A and related alkylphenols exert nongenomic estrogenic actions through a G protein-coupled estrogen receptor 1 (GPER)/epidermal growth factor receptor (EGFR) pathway to inhibit meiotic maturation of zebrafish oocytes10.1095/biolreprod.115.132316 ↗
54. Understanding the molecular mechanisms of bisphenol A action in spermatozoa10.5653/cerm.2019.00276 ↗
55. Gassman, N.R. (2022). Classical and non-classical estrogen receptor effects of bisphenol A. Bisphenol A: A Multi-Modal Endocrine Disruptor, Royal Society of Chemistry.10.1039/9781839166495 ↗
56. Low concentrations of bisphenol A suppress thyroid hormone receptor transcription through a nongenomic mechanism10.1016/j.taap.2011.12.018 ↗
57. Mechanisms of bisphenol A and its analogs as endocrine disruptors via nuclear receptors and related signaling pathways10.1007/s00204-025-04025-z ↗
58. Induction of oxidative stress by bisphenol A and its pleiotropic effects10.1002/em.22072 ↗
59. Bisphenol A induced oxidative stress mediated genotoxicity in Drosophila melanogaster10.1016/j.jhazmat.2018.07.050 ↗
60. Bisphenol A, bisphenol S, bisphenol F and bisphenol AF induce different oxidative stress and damage in human red blood cells (in vitro study)10.1016/j.tiv.2017.02.018 ↗
61. Sex-specific changes in oxidative stress parameters and longevity produced by bisphenol F and S compared to bisphenol A in Drosophila melanogaster10.1016/j.cbpc.2022.109329 ↗
62. Neuro-toxic and reproductive effects of BPA10.2174/1570159X17666190726112101 ↗
63. Bisphenol A induces testicular oxidative stress in mice leading to ferroptosis10.4103/aja202266 ↗
64. Unravelling bisphenol A-induced hepatotoxicity: Insights into oxidative stress, inflammation, and energy dysregulation10.1016/j.envpol.2024.124922 ↗
65. Caporossi, L., and Papaleo, B. (2017). Bisphenol A and metabolic diseases: Challenges for occupational medicine. Int. J. Environ. Res. Public Health, 14.10.3390/ijerph14090959 ↗
66. Moghazy, M., Papathanasiou, M., Tzoupis, H., Papavasileiou, K.D., Xing, C., Lauschke, V.M., Afantitis, A., and Melagraki, G. (2025). A systematic literature review of reproductive toxicological studies on phthalates. Int. J. Mol. Sci., 26.10.3390/ijms26188761 ↗
67. Ferroptosis is critical for phthalates driving the blood–testis barrier dysfunction via targeting transferrin receptor10.1016/j.redox.2022.102584 ↗
68. Oxidative stress and phthalate-induced down-regulation of steroidogenesis in MA-10 Leydig cells10.1016/j.reprotox.2013.07.025 ↗
69. Hlisníková, H., Petrovičová, I., Kolena, B., Šidlovská, M., and Sirotkin, A. (2020). Effects and mechanisms of phthalates’ action on reproductive processes and reproductive health: A literature review. Int. J. Environ. Res. Public Health, 17.10.3390/ijerph17186811 ↗
70. Impact of mono(2-ethylhexyl) phthalate (MEHP) on the development of mouse embryo in vitro10.1016/j.reprotox.2022.12.007 ↗
71. Exposure to DEHP and MEHP from hatching to adulthood causes reproductive dysfunction and endocrine disruption in marine medaka (Oryzias melastigma)10.1016/j.aquatox.2013.10.025 ↗
72. Mono-2-ethylhexylphthalate (MEHP) is a potent agonist of human TRPA1 channel10.1016/j.chemosphere.2023.140740 ↗
73. Mono-(2-ethylhexyl) phthalate (MEHP) promotes invasion and migration of human testicular embryonal carcinoma cells10.1095/biolreprod.111.097295 ↗
74. Mono-(2-ethylhexyl) phthalate-induced disruption of junctional complexes in the seminiferous epithelium of the rodent testis is mediated by MMP210.1095/biolreprod.109.080374 ↗
75. Phthalates and epigenetics: An emerging public health concern10.1016/j.crtox.2025.100267 ↗
76. Revealing the impact of mono(2-ethylhexyl) phthalate (MEHP) on prostate cancer based on network toxicology and molecular docking approaches10.1002/jat.4826 ↗
77. Chemical activity-based environmental risk analysis of the plasticizer di-ethylhexyl phthalate and its main metabolite mono-ethylhexyl phthalate10.1002/etc.3689 ↗
78. Exploring the reproductive exposure risks of phthalates and organophosphates in atmospheric particulate matter based on quantitative structure–activity relationships and network toxicology models10.1016/j.jhazmat.2025.137395 ↗
79. Wang, Y., and Qian, H. (2021). Phthalates and their impacts on human health. Healthcare, 9.10.3390/healthcare9050603 ↗
80. Mono-(2-ethylhexyl) phthalate regulates cholesterol efflux via microRNAs regulated m6A RNA methylation10.1021/acs.chemrestox.9b00367 ↗
81. The endocrine disruptor mono-(2-ethylhexyl) phthalate promotes adipocyte differentiation and induces obesity in mice10.1042/BSR20120042 ↗
82. Jia, Y., Liu, T., Zhou, L., Zhu, J., Wu, J., Sun, D., Xu, J., Wang, Q., Chen, H., and Xu, F. (2016). Effects of di-(2-ethylhexyl) phthalate on lipid metabolism by the JAK/STAT pathway in rats. Int. J. Environ. Res. Public Health, 13.10.3390/ijerph13111085 ↗
83. DEHP exposure destroys blood–testis barrier (BTB) integrity of immature testes through excessive ROS-mediated autophagy10.1016/j.gendis.2018.06.004 ↗
84. Absorption, distribution, and toxicity of per- and polyfluoroalkyl substances (PFAS) in the brain: A review10.1039/D1EM00228G ↗
85. Mišľanová, C., and Valachovičová, M. (2025). Health impacts of per- and polyfluoroalkyl substances (PFASs): A comprehensive review. Life, 15.10.3390/life15040573 ↗
86. Per- and polyfluoroalkyl substance toxicity and human health review: Current state of knowledge and strategies for informing future research10.1002/etc.4890 ↗
87. PFAS exposure and male reproductive health: Implications for sperm epigenetics10.1055/s-0044-1801363 ↗
88. Association between exposure to per- and perfluoroalkyl substances (PFAS) and reproductive hormones in human: A systematic review and meta-analysis10.1016/j.envres.2023.117553 ↗
89. Per- and polyfluoroalkyl substances (PFAS): Immunotoxicity at the primary sites of exposure10.1080/10408444.2025.2501420 ↗
90. Emerging toxicological awareness of per- and polyfluoroalkyl substances: The rising concern over “forever chemicals”10.1242/dmm.052647 ↗
91. Brenckman, C.M., Borgaonkar, A.D., Pennock, W.H., and Meegoda, J.N. (2026). Combined environmental impacts and toxicological interactions of per- and polyfluoroalkyl substances (PFAS) and microplastics (MPs). Environments, 13.10.3390/environments13010038 ↗
92. Neurotransmission targets of per- and polyfluoroalkyl substance neurotoxicity: Mechanisms and potential implications for adverse neurological outcomes10.1021/acs.chemrestox.2c00072 ↗
93. Brunetti, K., Galletti, G.S., Catalani, E., Cervia, D., and Del Quondam, S. (2025). From exposure to dysfunction: The intestinal toxicity of per- and polyfluoroalkyl substances. Toxics, 14.10.3390/toxics14010039 ↗
94. Health-related toxicity of emerging per- and polyfluoroalkyl substances: Comparison to legacy PFOS and PFOA10.1016/j.envres.2022.113431 ↗
95. Per- and polyfluoroalkyl substances (PFAS) in senior care facilities and older adult residents10.1016/j.scitotenv.2024.172316 ↗
96. Monitoring of per- and polyfluoroalkyl substances (PFAS) in human blood samples collected in three regions with known PFAS releases in the environment and three control regions in South Germany10.1007/s00204-024-03843-x ↗
97. Per- and polyfluoroalkyl substances in blood plasma—Results of the German Environmental Survey for children and adolescents 2014–2017 (GerES V)10.1016/j.ijheh.2020.113549 ↗
98. Early-life exposure to per- and polyfluoroalkyl substances: Analysis of levels, health risk and binding abilities to transport proteins10.1016/j.eehl.2024.04.007 ↗
99. PFAS (per- and polyfluoroalkyl substances) and asthma in young children: NHANES 2013–201410.1016/j.ijheh.2020.113565 ↗
100. Association between per- and polyfluoroalkyl substances exposure and prevalence of chronic obstructive pulmonary disease: The mediating role of serum albumin10.1016/j.scitotenv.2024.171742 ↗